Management strategies in antithrombotic therapy /

Mostrar otras versiones (1)

Intravascular thrombus formation remains one of the most significant problems in cardiovascular medicine. It underlies the clinical presentation of acute coronary syndromes, including unstable angina and non-ST-segment elevation myocardial infarction (NSTEMI) and ST-segment elevation myocardial infa...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Askari, Arman T.
Otros Autores: Messerli, Adrian W.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Chichester ; Hoboken, N.J. : John Wiley and Sons, ©2007.
Temas:
Thrombolytic therapy.
Thrombosis > Treatment.
Fibrinolytic agents.
Coronary Thrombosis > drug therapy
Heart Diseases > drug therapy
Fibrinolytic Agents > therapeutic use
Thrombolytic Therapy
Fibrinolytic Agents
Thrombolyse.
Thrombose > Traitement.
Fibrinolytiques.
MEDICAL > Cardiology.
Fibrinolytic agents
Thrombolytic therapy
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Thrombosis and antithrombotics in vascular disease
  • Aspirin
  • Thienopyridines, ticlopidine, and clopidogrel
  • Platelet glycoprotein IIb/IIIa inhibitors
  • Unfractionated heparin
  • Low-molecular-weight heparins
  • Direct thrombin inhibitors
  • Fibrinolytic agents
  • Acute ST-segment elevation myocardial infarction
  • Acute coronary syndromes / non-ST-segment elevation myocardial infarction
  • Anticoagulation strategies for patients undergoing percutaneous coronary intervention
  • Venous thromboembolic disease
  • Heparin-induced thrombocytopenia.

Ejemplares similares